Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Chemotherapy was not associated with cognitive decline in older adults with breast and colorectal cancer: findings from a prospective cohort study.

Shaffer VA, Merkle EC, Fagerlin A, Griggs JJ, Langa KM, Iwashyna TJ.

Med Care. 2012 Oct;50(10):849-55. doi: 10.1097/MLR.0b013e31825a8bb0.

2.

A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients.

Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA.

Support Care Cancer. 2011 Oct;19(10):1647-56. doi: 10.1007/s00520-010-0997-4. Epub 2010 Sep 5.

PMID:
20820813
3.

The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.

Stewart A, Collins B, Mackenzie J, Tomiak E, Verma S, Bielajew C.

Psychooncology. 2008 Feb;17(2):122-30.

PMID:
17518411
4.

Association between chemotherapy and cognitive impairments in a large cohort of patients with colorectal cancer.

Du XL, Cai Y, Symanski E.

Int J Oncol. 2013 Jun;42(6):2123-33. doi: 10.3892/ijo.2013.1882. Epub 2013 Apr 4.

PMID:
23563930
5.
6.

Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.

Jim HS, Phillips KM, Chait S, Faul LA, Popa MA, Lee YH, Hussin MG, Jacobsen PB, Small BJ.

J Clin Oncol. 2012 Oct 10;30(29):3578-87. doi: 10.1200/JCO.2011.39.5640. Epub 2012 Aug 27. Review.

7.

Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.

Hurria A, Rosen C, Hudis C, Zuckerman E, Panageas KS, Lachs MS, Witmer M, van Gorp WG, Fornier M, D'Andrea G, Moasser M, Dang C, Van Poznak C, Hurria A, Holland J.

J Am Geriatr Soc. 2006 Jun;54(6):925-31.

PMID:
16776787
8.

Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.

Hurria A, Goldfarb S, Rosen C, Holland J, Zuckerman E, Lachs MS, Witmer M, van Gorp WG, Fornier M, D'Andrea G, Moasser M, Dang C, Van Poznak C, Robson M, Currie VE, Theodoulou M, Norton L, Hudis C.

Breast Cancer Res Treat. 2006 Aug;98(3):343-8. Epub 2006 Mar 16.

PMID:
16541322
9.

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.

Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS.

J Natl Cancer Inst. 2006 Dec 6;98(23):1742-5.

PMID:
17148777
10.

Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy.

Collins B, Mackenzie J, Tasca GA, Scherling C, Smith A.

J Int Neuropsychol Soc. 2014 Apr;20(4):370-9. doi: 10.1017/S1355617713001215. Epub 2013 Nov 15.

PMID:
24229809
11.

Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study.

Vardy JL, Dhillon HM, Pond GR, Rourke SB, Bekele T, Renton C, Dodd A, Zhang H, Beale P, Clarke S, Tannock IF.

J Clin Oncol. 2015 Dec 1;33(34):4085-92. doi: 10.1200/JCO.2015.63.0905. Epub 2015 Nov 2.

PMID:
26527785
12.

Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer.

Griffiths RI, Barron RL, Gleeson ML, Danese MD, O'Hagan A, Chia VM, Legg JC, Lyman GH.

Pharmacoeconomics. 2012 Feb 1;30(2):103-18. doi: 10.2165/11589440-000000000-00000.

PMID:
21967155
13.

A prospective cohort study of long-term cognitive changes in older Medicare beneficiaries.

Wolinsky FD, Bentler SE, Hockenberry J, Jones MP, Weigel PA, Kaskie B, Wallace RB.

BMC Public Health. 2011 Sep 20;11:710. doi: 10.1186/1471-2458-11-710.

14.

Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.

Jansen CE, Dodd MJ, Miaskowski CA, Dowling GA, Kramer J.

Psychooncology. 2008 Dec;17(12):1189-95. doi: 10.1002/pon.1342.

PMID:
18506671
15.

[The estimation of premorbid intelligence levels in French speakers].

Mackinnon A, Mulligan R.

Encephale. 2005 Jan-Feb;31(1 Pt 1):31-43. French.

PMID:
15971638
16.
17.

Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.

Fan HG, Houédé-Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K, Tannock IF.

J Clin Oncol. 2005 Nov 1;23(31):8025-32.

PMID:
16258100
18.

Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.

Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA.

J Clin Exp Neuropsychol. 2004 Oct;26(7):955-69.

PMID:
15742545
19.

Patterns of change in cognitive function with anastrozole therapy.

Bender CM, Merriman JD, Gentry AL, Ahrendt GM, Berga SL, Brufsky AM, Casillo FE, Dailey MM, Erickson KI, Kratofil FM, McAuliffe PF, Rosenzweig MQ, Ryan CM, Sereika SM.

Cancer. 2015 Aug 1;121(15):2627-36. doi: 10.1002/cncr.29393. Epub 2015 Apr 23.

20.

Decline in cognitive and functional skills increases mortality risk in nondemented elderly.

Schupf N, Tang MX, Albert SM, Costa R, Andrews H, Lee JH, Mayeux R.

Neurology. 2005 Oct 25;65(8):1218-26.

PMID:
16247048

Supplemental Content

Support Center